Home Imidazoles 13551-87-6
13551-87-6,MFCD28400586
Catalog No.:AA009HRT

13551-87-6 | 1-Methoxy-3-(2-nitro-1H-imidazol-1-yl)propan-2-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$89.00   $62.00
- +
5mg
≥95%
in stock  
$153.00   $107.00
- +
10mg
≥95%
in stock  
$216.00   $151.00
- +
50mg
≥95%
in stock  
$510.00   $357.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA009HRT
Chemical Name:
1-Methoxy-3-(2-nitro-1H-imidazol-1-yl)propan-2-ol
CAS Number:
13551-87-6
Molecular Formula:
C7H11N3O4
Molecular Weight:
201.1799
MDL Number:
MFCD28400586
SMILES:
[O-][N+](=O)c1nccn1CC(COC)O
NSC Number:
261037
Properties
Computed Properties
 
Complexity:
196  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
1  
XLogP3:
-0.4  

Literature

Title: Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.

Journal: International journal of radiation oncology, biology, physics 20121101

Title: Dose-response relationships of FMISO between trace dose and various macro-doses in rat by ultra-performance liquid chromatography with mass spectrometry and radioactivity analysis.

Journal: Journal of pharmaceutical and biomedical analysis 20121101

Title: Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma.

Journal: International journal of oncology 20121101

Title: Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120801

Title: Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.

Journal: Journal of medicinal chemistry 20120712

Title: Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas.

Journal: Nuclear medicine communications 20120601

Title: ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.

Journal: European journal of nuclear medicine and molecular imaging 20120501

Title: Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.

Journal: Physics in medicine and biology 20120321

Title: Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.

Journal: Mathematical medicine and biology : a journal of the IMA 20120301

Title: Implementation of hypoxia measurement into lung cancer therapy.

Journal: Lung cancer (Amsterdam, Netherlands) 20120201

Title: Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports.

Journal: Japanese journal of clinical oncology 20120201

Title: The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors.

Journal: International journal of surgical oncology 20120101

Title: Tumor blood flow differs between mouse strains: consequences for vasoresponse to photodynamic therapy.

Journal: PloS one 20120101

Title: Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy.

Journal: Frontiers in pharmacology 20120101

Title: Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20111201

Title: Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma.

Journal: Clinical nuclear medicine 20111201

Title: 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.

Journal: Annals of nuclear medicine 20111101

Title: PET imaging of cardiac hypoxia: opportunities and challenges.

Journal: Journal of molecular and cellular cardiology 20111101

Title: Secondary gliosarcoma after the treatment of primary glioblastoma multiforme.

Journal: North American journal of medical sciences 20111101

Title: Anti-VEGF antibody treatment accelerates polycystic kidney disease.

Journal: American journal of physiology. Renal physiology 20111001

Title: Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.

Journal: Journal of neuro-oncology 20110801

Title: Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.

Journal: Nuclear medicine and biology 20110801

Title: Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.

Journal: Nuclear medicine and biology 20110801

Title: Metastatic renal cell carcinoma: relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: an 18F-fluoromisonidazole PET/CT study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110701

Title: In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis.

Journal: PLoS pathogens 20110701

Title: Evaluation of hypoxic tissue dynamics with 18F-FMISO PET in a rat model of permanent cerebral ischemia.

Journal: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20110601

Title: Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.

Journal: Gynecologic oncology 20110601

Title: Comparison of (immuno-)fluorescence data with serial [¹⁸F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110601

Title: Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps.

Journal: Physics in medicine and biology 20110407

Title: Reduction of [(18)F]fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma.

Journal: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20110401

Title: Radiosynthesis of the tumor hypoxia marker [18F]TFMISO via O-[18F]trifluoroethylation reveals a striking difference between trifluoroethyl tosylate and iodide in regiochemical reactivity toward oxygen nucleophiles.

Journal: Bioorganic & medicinal chemistry 20110401

Title: Multiagent PET for risk characterization in sarcoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110401

Title: Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.

Journal: International journal of radiation oncology, biology, physics 20110315

Title: 'Salvaged' stroke ischaemic penumbra shows significant injury: studies with the hypoxia tracer FMISO.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110301

Title: Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.

Journal: European journal of nuclear medicine and molecular imaging 20110301

Title: 18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110301

Title: Parametric mapping of [18F]fluoromisonidazole positron emission tomography using basis functions.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110201

Title: Molecular imaging of hypoxia.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110201

Title: Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110101

Title: Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?

Journal: Nuklearmedizin. Nuclear medicine 20110101

Title: Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.

Journal: PloS one 20110101

Title: Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.

Journal: PloS one 20110101

Title: Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.

Journal: Radiation oncology (London, England) 20110101

Title: Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone.

Journal: Radiation oncology (London, England) 20110101

Title: Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected review.

Journal: Nuclear medicine review. Central & Eastern Europe 20110101

Title: Combined modality approaches in the management of adult glioblastoma.

Journal: Frontiers in oncology 20110101

Title: The possibility of a fully automated procedure for radiosynthesis of fluorine-18-labeled fluoromisonidazole using a simplified single, neutral alumina column purification procedure.

Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20101001

Title: Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.

Journal: Acta oncologica (Stockholm, Sweden) 20101001

Title: PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100901

Title: Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.

Journal: International journal of radiation oncology, biology, physics 20100801

Title: Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.

Journal: Nuclear medicine and biology 20100701

Title: Simulation of tissue activity curves of (64)Cu-ATSM for sub-target volume delineation in radiotherapy.

Journal: Physics in medicine and biology 20100207

Title: Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.

Journal: Journal of neuro-oncology 20100201

Title: Influence of manipulating hypoxia in solid tumors on the radiation dose-rate effect in vivo, with reference to that in the quiescent cell population.

Journal: Japanese journal of radiology 20100201

Title: Imaging of hypoxic-ischemic penumbra with (18)F-fluoromisonidazole PET/CT and measurement of related cerebral metabolism in aneurysmal subarachnoid hemorrhage.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20100101

Title: The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Journal: Journal of neuro-oncology 20100101

Title: The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Journal: Journal of neuro-oncology 20100101

Title: Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100101

Title: Partial pulmonary embolization disrupts alveolarization in fetal sheep.

Journal: Respiratory research 20100101

Title: Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysis.

Journal: Radiation oncology (London, England) 20100101

Title: HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia.

Journal: PloS one 20100101

Title: A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy.

Journal: British journal of cancer 20091201

Title: Design of silicon-based misonidazole analogues and (18)F-radiolabelling.

Journal: Nuclear medicine and biology 20091101

Title: A robotic system for 18F-FMISO PET-guided intratumoral pO2 measurements.

Journal: Medical physics 20091101

Title: Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET.

Journal: Medical physics 20091001

Title: Characterisation of the timing of binding of the hypoxia tracer FMISO after stroke.

Journal: Brain research 20090908

Title: Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.

Journal: International journal of radiation oncology, biology, physics 20090901

Title: Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.

Journal: Physics in medicine and biology 20090521

Title: Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.

Journal: Cancer research 20090515

Title: Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.

Journal: Nuclear medicine and biology 20090401

Title: Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.

Journal: Neoplasia (New York, N.Y.) 20090301

Title: [Advances in research on hypoxic imaging in cancer radiotherapy].

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090301

Title: Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.

Journal: Bioorganic & medicinal chemistry 20090215

Title: [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.

Journal: European journal of nuclear medicine and molecular imaging 20090201

Title: Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20090101

Title: Whole brain radiotherapy with radiosensitizer for brain metastases.

Journal: Journal of experimental & clinical cancer research : CR 20090101

Title: Stereotactic radiosurgery for glioblastoma: retrospective analysis.

Journal: Radiation oncology (London, England) 20090101

Title: Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.

Journal: Molecular cancer 20090101

Title: Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20081201

Title: Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.

Journal: Cancer research 20081015

Title: Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.

Journal: European journal of nuclear medicine and molecular imaging 20081001

Title: Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.

Journal: Nuclear medicine and biology 20080801

Title: Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20080601

Title: Novel imaging approaches to head and neck cancer.

Journal: Seminars in oncology 20080601

Title: Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20080501

Title: The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.

Journal: International journal of radiation oncology, biology, physics 20080315

Title: Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.

Journal: European journal of nuclear medicine and molecular imaging 20080101

Title: Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.

Journal: International journal of radiation oncology, biology, physics 20080101

Title: Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

Journal: International journal of radiation oncology, biology, physics 20080101

Title: PET for sarcomas other than gastrointestinal stromal tumors.

Journal: The oncologist 20080101

Title: Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG?

Journal: Acta oncologica (Stockholm, Sweden) 20080101

Title: Neuropsychological testing and biomarkers in the management of brain metastases.

Journal: Radiation oncology (London, England) 20080101

Title: Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.

Journal: Seminars in nuclear medicine 20071101

Title: Interventions for preventing oral mucositis for patients with cancer receiving treatment.

Journal: The Cochrane database of systematic reviews 20071017

Title: Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels' activation in a genetic model of amyotrophic lateral sclerosis.

Journal: Neurobiology of disease 20071001

Title: [Molecular design of hypoxic tumor cell-targeting drugs and imaging probes].

Journal: Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme 20071001

Title: Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro: comparison of different tumor cells and primary endothelial cells.

Journal: Cancer letters 20070828

Title: In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20070615

Title: A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO).

Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20070601

Title: A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations.

Journal: International journal of radiation oncology, biology, physics 20070601

Title: In vivo molecular imaging biomarkers: clinical pharmacology's new 'PET'?

Journal: Clinical pharmacology and therapeutics 20070601

Title: Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20070601

Title: Canadian recommendations for the treatment of glioblastoma multiforme.

Journal: Current oncology (Toronto, Ont.) 20070601

Title: Hypoxia dose painting by numbers: a planning study.

Journal: International journal of radiation oncology, biology, physics 20070501

Title: Imaging of brain hypoxia in permanent and temporary middle cerebral artery occlusion in the rat using 18F-fluoromisonidazole and positron emission tomography: a pilot study.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070401

Title: The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography.

Journal: International journal of oncology 20070401

Title: Imaging tumoral hypoxia: oxygen concentrations and beyond.

Journal: Oncology (Williston Park, N.Y.) 20070301

Title: Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer.

Journal: International journal of nanomedicine 20070301

Title: Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.

Journal: BMC cancer 20070101

Title: pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?

Journal: BMC cancer 20070101

Title: Hypertabastic survival model.

Journal: Theoretical biology & medical modelling 20070101

Title: FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.

Journal: European journal of nuclear medicine and molecular imaging 20061201

Title: Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20061201

Title: A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data.

Journal: Physics in medicine and biology 20061121

Title: Tumor hypoxia imaging.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060915

Title: Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060915

Title: Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20060801

Title: Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20060801

Title: Characterization of fluoromisonidazole binding in stroke.

Journal: Stroke 20060701

Title: Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060601

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060501

Title: Interventions for preventing oral mucositis for patients with cancer receiving treatment.

Journal: The Cochrane database of systematic reviews 20060419

Title: NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours.

Journal: European journal of nuclear medicine and molecular imaging 20060301

Title: Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20060301

Title: Potentiation of the cytotoxicity of the anticancer agent tirapazamine by benzotriazine N-oxides: the role of redox equilibria.

Journal: Journal of the American Chemical Society 20060111

Title: A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.

Journal: BMC cancer 20060101

Title: Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors.

Journal: Nuclear medicine and biology 20060101

Title: Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy.

Journal: Journal of translational medicine 20060101

Title: [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.

Journal: BMC cancer 20060101

Title: Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.

Journal: Anticancer research 20060101

Title: Radiosensitizers in cervical cancer. Cisplatin and beyond.

Journal: Radiation oncology (London, England) 20060101

Title: From anatomical to biological target volumes: the role of PET in radiation treatment planning.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society 20060101

Title: PET imaging of tumour hypoxia.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society 20060101

Title: CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

Journal: Journal of biology 20060101

Title: Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module.

Journal: Nuclear medicine and biology 20051101

Title: Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography.

Journal: BJU international 20050901

Title: Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.

Journal: International journal of radiation oncology, biology, physics 20050701

Title: Fully automated one-pot synthesis of [18F]fluoromisonidazole.

Journal: Nuclear medicine and biology 20050701

Title: A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

Journal: Physics in medicine and biology 20050521

Title: Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.

Journal: International journal of radiation oncology, biology, physics 20050401

Title: Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study.

Journal: British journal of cancer 20050314

Title: Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.

Journal: British journal of cancer 20050227

Title: Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050201

Title: Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050101

Title: Clinical practice guideline on the optimal radiotherapeutic management of brain metastases.

Journal: BMC cancer 20050101

Title: Imaging of the ischemic penumbra in acute stroke.

Journal: Korean journal of radiology 20050101

Title: Iodinated nitroimidazoles as radiosensitizers.

Journal: Anticancer research 20050101

Title: Measurement of tumor hypoxia in spontaneous canine sarcomas.

Journal: Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 20050101

Title: Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.

Journal: BMC cancer 20050101

Title: Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry.

Journal: British journal of cancer 20041129

Title: A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.

Journal: European journal of nuclear medicine and molecular imaging 20041101

Title: The resistance to ischemia of white and gray matter after stroke.

Journal: Annals of neurology 20041101

Title: Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20041101

Title: pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20041001

Title: Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival.

Journal: Brain : a journal of neurology 20040601

Title: In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography.

Journal: British journal of cancer 20040601

Title: Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.

Journal: European journal of nuclear medicine and molecular imaging 20040401

Title: Imaging the ischemic penumbra with 18F-fluoromisonidazole in a rat model of ischemic stroke.

Journal: Stroke 20040401

Title: Penumbral topography in human stroke: methodology and validation of the 'Penumbragram'.

Journal: NeuroImage 20040401

Title: A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20040301

Title: Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas.

Journal: British journal of cancer 20040209

Title: Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.

Journal: Cancer research 20040115

Title: Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.

Journal: European journal of nuclear medicine and molecular imaging 20040101

Title: Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke.

Journal: Stroke 20031101

Title: GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.

Journal: British journal of cancer 20031006

Title: Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer.

Journal: British journal of cancer 20030721

Title: Nitroheterocyclic drugs with broad spectrum activity.

Journal: Parasitology research 20030601

Title: Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20030601

Title: Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.

Journal: British journal of cancer 20030506

Title: [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.

Journal: European journal of nuclear medicine and molecular imaging 20030501

Title: Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models.

Journal: Nuclear medicine communications 20030501

Title: [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.

Journal: Nuclear medicine and biology 20030401

Title: Developments in radiotherapy and adjuvant chemotherapy for head and neck cancer.

Journal: Clinical otolaryngology and allied sciences 20030201

Title: A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.

Journal: British journal of cancer 20030127

Title: On biologically conformal boost dose optimization.

Journal: Physics in medicine and biology 20030121

Title: A systematic overview of radiation therapy effects in urinary bladder cancer.

Journal: Acta oncologica (Stockholm, Sweden) 20030101

Title: 18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studies.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20021201

Title: DNA-targeted 2-nitroimidazoles: studies of the influence of the phenanthridine-linked nitroimidazoles, 2-NLP-3 and 2-NLP-4, on DNA damage induced by ionizing radiation.

Journal: Radiation research 20020901

Title: The range of oxygenation in SiHa tumor xenografts.

Journal: Radiation research 20020801

Title: Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours.

Journal: Gene therapy 20020701

Title: Statistical parametric mapping of hypoxic tissue identified by [(18)F]fluoromisonidazole and positron emission tomography following acute ischemic stroke.

Journal: NeuroImage 20020601

Title: Synthesis and evaluation of 4-bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targeting imaging agent.

Journal: Biological & pharmaceutical bulletin 20020501

Title: External-beam radiotherapy in the management of liver metastases.

Journal: Seminars in oncology 20020401

Title: Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells.

Journal: British journal of cancer 20020212

Title: Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO).

Journal: Nuclear medicine and biology 20020201

Title: Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing.

Journal: Acta oncologica (Stockholm, Sweden) 20020101

Title: Hypoxia regulates avian cardiac Arnt and HIF-1alpha mRNA expression.

Journal: Biochemical and biophysical research communications 20010330

Title: Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115

Title: Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.

Journal: Bioorganic & medicinal chemistry 19970301

Title: Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice.

Journal: Japanese journal of cancer research : Gann 19960901

Title: Neurotoxicity of misonidazole in rats following intravenous administration.

Journal: Pharmacological research 19960601

Title: The same chemicals induce different neurotoxicity when administered in high doses for short term or low doses for long term to rats and dogs.

Journal: Molecular and chemical neuropathology 19920101

Title: Non-invasive MRS in new anticancer drug development.

Journal: NMR in biomedicine 19920101

Title: Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.

Journal: British journal of cancer 19920101

Title: The effect of radiosensitizers on radio-immunotherapy, using 131I-labelled anti-CEA antibodies in a human colonic xenograft model.

Journal: International journal of cancer 19910220

Title: Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use.

Journal: International journal of radiation biology 19910101

Title: Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.

Journal: Anti-cancer drug design 19900201

Title: The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15.

Journal: International journal of radiation oncology, biology, physics 19891201

Title: Hypoxic toxicity of misonidazole in a glucose-6-phosphate dehydrogenase deficient mutant Chinese hamster ovary cell line.

Journal: International journal of radiation oncology, biology, physics 19881001

Title: The radiosensitizing effects of misonidazole (MISO) in combination with diethyl maleate (DEM) in mouse mammary tumors.

Journal: International journal of radiation oncology, biology, physics 19861001

Title: Radiosensitizing effect of misonidazole in combination with an inhibitor of glutathione synthesis in murine tumors.

Journal: International journal of radiation oncology, biology, physics 19860901

Title: Effect of misonidazole on neurotransmitter systems.

Journal: International journal of radiation oncology, biology, physics 19860701

Title: Enhancement in the aerobic toxicity of misonidazole and SR-2508 by buthionine sulfoximine and 4-hydroxypyrazole: the role of hydrogen peroxide.

Journal: International journal of radiation oncology, biology, physics 19860701

Title: Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.

Journal: Cancer research 19860601

Title: Biochemistry of misonidazole reduction by NADPH-cytochrome c (P-450) reductase.

Journal: Molecular pharmacology 19860201

Title: Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.

Journal: Cancer chemotherapy and pharmacology 19860101

Title: Effect of hypoxic cell radiosensitizers on glutathione level and related enzyme activities in isolated rat hepatocytes.

Journal: Life sciences 19850819

Title: Radiosensitizing and cytotoxic properties of misonidazole on glutathione synthetase deficient human fibroblasts.

Journal: International journal of radiation biology and related studies in physics, chemistry, and medicine 19850801

Title: Neurotoxicity of Adriamycin and misonidazole in the mouse.

Journal: Experimental neurology 19850101

Title: The neurotoxicity of radiosensitizing drugs: a biochemical assessment of desmethylmisonidazole (DMM) in the rat.

Journal: Toxicology 19850101

Title: Oncogenic transformation systems involving mammalian cells in vitro to determine the relative risks of different treatment modalities.

Journal: Strahlentherapie 19841201

Title: Drug testing using a soft agar stem cell assay on patient and xenograft tumor material.

Journal: International journal of radiation oncology, biology, physics 19840901

Title: Association of the radiosensitizers metronidazole and misonidazole (RO-07-0582) with bovine serum albumin. Effect of urea and ionic strength.

Journal: International journal of radiation biology and related studies in physics, chemistry, and medicine 19840801

Title: The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.

Journal: British journal of cancer 19840201

Title: The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.

Journal: The British journal of radiology 19831101

Title: Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.

Journal: British journal of cancer 19831101

Title: The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.

Journal: The British journal of radiology 19831001

Title: The role of dexamethasone in the modification of misonidazole pharmacokinetics.

Journal: British journal of cancer 19831001

Title: Protection against misonidazole-induced neuropathy in rats: a biochemical assessment.

Journal: Toxicology letters 19830601

Title: Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.

Journal: British journal of cancer 19830501

Title: Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.

Journal: Cancer treatment reports 19830301

Title: Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase.

Journal: Biochemical pharmacology 19821015

Title: Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.

Journal: British journal of cancer 19820801

Title: Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.

Journal: British journal of cancer 19820401

Title: Activation of misonidazole by rat liver microsomes and purified NADPH-cytochrome c reductase.

Journal: Biochemical pharmacology 19820215

Title: Reductive activation of nitroaromatics and enzyme inhibition: misonidazole and xanthine oxidase.

Journal: International journal of radiation oncology, biology, physics 19820101

Title: Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships.

Journal: International journal of radiation oncology, biology, physics 19820101

Title: Neurotoxicity of radiation sensitizers in the mouse.

Journal: International journal of radiation oncology, biology, physics 19820101

Title: A biochemical assessment of the neurotoxicity of the radiosensitizing drug misonidazole in the rat.

Journal: Clinical toxicology 19811201

Title: A biochemical method for assessing the neurotoxic effects of misonidazole in the rat.

Journal: British journal of cancer 19801201

Title: Structure-function dependence and allopurinol inhibition of radiosensitizer/nitroreductase interaction: approaches to improving therapeutic ratios.

Journal: Cancer clinical trials 19800101

Title: Binding of nitroreduction products of misonidazole to nucleic acids and protein.

Journal: Cancer clinical trials 19800101

Title: Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.

Journal: British journal of cancer 19790901

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 13551-87-6
Tags:13551-87-6 Molecular Formula|13551-87-6 MDL|13551-87-6 SMILES|13551-87-6 1-Methoxy-3-(2-nitro-1H-imidazol-1-yl)propan-2-ol